Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Antiplatelet drugs block platelet activation by VITT patient serum

Christopher W. Smith, Samantha J. Montague, Caroline Kardeby, Ying Di, Gillian C. Lowe, William A. Lester, Steve P. Watson, Phillip L. R. Nicolson

Blood (2021) 138 (25): 2733–2740.

https://doi.org/10.1182/blood.2021012277

Published: 2021

Includes: Supplemental data

Journal Articles

Mutation in GNE is associated with severe congenital thrombocytopenia

Jane Futterer, Amanda Dalby, Gillian C. Lowe, Ben Johnson, Michael A. Simpson, Jayashree Motwani, Mike Williams, Steve P. Watson, Neil V. Morgan

Blood (2018) 132 (17): 1855–1858.

https://doi.org/10.1182/blood-2018-04-847798

Published: 2018

Includes: Supplemental data

Journal Articles

Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay

Marie Lordkipanidzé, Gillian C. Lowe, Nicholas S. Kirkby, Melissa V. Chan, Martina H. Lundberg, Neil V. Morgan, Danai Bem, Shaista P. Nisar, Vincenzo C. Leo, Matthew L. Jones, Stuart J. Mundell, Martina E. Daly, Andrew D. Mumford, Timothy D. Warner, Steve P. Watson

Blood (2014) 123 (8): e11–e22.

https://doi.org/10.1182/blood-2013-08-520387

Published: 2014

Includes: Supplemental data

Journal Articles

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects

Jacqueline Stockley, Neil V. Morgan, Danai Bem, Gillian C. Lowe, Marie Lordkipanidzé, Ban Dawood, Michael A. Simpson, Kirsty Macfarlane, Kevin Horner, Vincenzo C. Leo, Katherine Talks, Jayashree Motwani, Jonathan T. Wilde, Peter W. Collins, Michael Makris, Steve P. Watson, Martina E. Daly

Blood (2013) 122 (25): 4090–4093.

https://doi.org/10.1182/blood-2013-06-506873

Published: 2013

Includes: Supplemental data

Journal Articles

Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel

Ban B. Dawood, Gillian C. Lowe, Marie Lordkipanidzé, Danai Bem, Martina E. Daly, Mike Makris, Andrew Mumford, Jonathan T. Wilde, Steve P. Watson

Blood (2012) 120 (25): 5041–5049.

https://doi.org/10.1182/blood-2012-07-444281

Published: 2012

Includes: Supplemental data

NARROW

Antiplatelet drugs block platelet activation by VITT patient serum

Mutation in GNE is associated with severe congenital thrombocytopenia

Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects

Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel

Email alerts

ASH Publications

American Society of Hematology

Antiplatelet drugs block platelet activation by VITT patient serum

Mutation in GNE is associated with severe congenital thrombocytopenia

Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay

Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects

Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only